John P. Iwanicki discusses how the Supreme Court will approach the question of whether a single genetic testing kit component is sufficient to meet the test of a “substantial portion” of a potentially infringing article in the Medical Device Daily article, “Bright-Line Test in Promega Seen as a No-Go.”
Click here to read the article (subscription required).
Posted: December 8, 2016
